On August 12, 2026, the Board of Directors appointed Carol L. Brosgart as a director effective immediately. No arrangements or understandings exist between Ms. Brosgart and other persons regarding her selection, there are no family relationships with existing directors or executive officers, and no related party transactions require disclosure. Cocrystal Pharma, Inc. operates in the biotechnology industry, focusing on the discovery and development of antiviral drugs.
